Pharma & Biotech

Bionxt Solutions has announced a major strategic expansion, positioning itself to access a multi-billion dollar segment within the oncology and...

Shares of Intellia Therapeutics are experiencing significant downward pressure, with the stock price declining 3.80% to $8.10 as investor sentiment...

Investors in Ocugen are facing a critical test of resolve. The biotech firm's shares have been under persistent downward pressure,...

Pharmaceutical titan Eli Lilly has launched an aggressive offensive in the lucrative weight-loss drug sector, initiating a price war that...

The shares of Viking Therapeutics have delivered a remarkable 34% gain over the past three months, signaling a powerful resurgence....

The pharmaceutical titan Eli Lilly has escalated competition in the high-growth weight-loss medication sector with a bold pricing maneuver. By...

A significant shift in analyst sentiment is casting a shadow over Intellia Therapeutics, sending its stock downward and prompting investors...

Shares of healthcare distributor Henry Schein are trading lower in the current session, despite the company announcing two significant strategic...

A major strategic alliance and a wave of bullish analyst revisions are fueling a significant rally in Iqvia Holdings Inc....

Despite a recent share price decline, Summit Therapeutics finds itself at a pivotal moment, with significant insider purchases and bullish...